MEREDITH CHESARE
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant SYRACUSE, NY NPI 1922636364
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant NY Intrinsic Therapeutics All categories
General Payments — all program years on this page
$587.95
- Category: General Payments
- Program years: PY2021–2024
- Record count: 19
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $279.69 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $279.69 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Intrinsic Therapeutics | $136.82 | 1 |
| Teva Pharmaceuticals USA, Inc. | $42.17 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $38.66 | 2 |
| Amgen Inc. | $23.35 | 1 |
| SK Life Science, Inc. | $20.38 | 1 |
| Lundbeck LLC | $18.31 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1117222887 | Amgen Inc. | $23.35 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144443096 | CATALYST PHARMACEUTICALS, INC. | $20.38 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144443098 | CATALYST PHARMACEUTICALS, INC. | $18.28 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144702034 | Intrinsic Therapeutics | $136.82 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146005073 | Lundbeck LLC | $18.31 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151644143 | Teva Pharmaceuticals USA, Inc. | $24.21 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151644159 | Teva Pharmaceuticals USA, Inc. | $17.96 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154135574 | SK Life Science, Inc. | $20.38 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.